Candriam SCA’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $79.5M | Sell |
|
|||||
|
2021
Q2 | $69.9M | Buy |
|
|||||
|
2021
Q1 | $68.4M | Sell |
|
|||||
|
2020
Q4 | $71.3M | Buy |
|
|||||
|
2020
Q3 | $56.9M | Buy |
|
|||||
|
2020
Q2 | $36.3M | Sell |
|
|||||
|
2020
Q1 | $25M | Buy |
|
|||||
|
2019
Q4 | $25.6M | Sell |
|
|||||
|
2019
Q3 | $21.8M | Buy |
|
|||||
|
2019
Q2 | $15.6M | Buy |
|
|||||
|
2019
Q1 | $11.2M | Sell |
|
|||||
|
2018
Q4 | $10.6M | Buy |
|
|||||
|
2018
Q3 | $7.15M | Buy |
|
|||||
|
2018
Q2 | $4.71M | Buy |
|
|||||
|
2018
Q1 | $2.35M | Sell |
|
|||||
|
2017
Q4 | $3.1M | Sell |
|
|||||
|
2017
Q3 | $4.4M | Buy |
|
|||||
|
2017
Q2 | $3.28M | Sell |
|
|||||
|
2017
Q1 | $4.82M | Buy |
|
|||||
|
2016
Q4 | $3.85M | Buy |
|
|||||
|
2016
Q3 | $3.4M | Buy |
|
|||||
|
2016
Q2 | $2.72M | Sell |
|
|||||
|
2016
Q1 | $3.02M | Sell |
|
|||||
|
2015
Q4 | $5.85M | Buy |
|
|||||
|
2015
Q3 | $2.51M | Buy |
|
|||||
|
2015
Q2 | $3.16M | Buy |
|
|||||
|
2015
Q1 | $2.59M | Buy |
|
|||||
|
2014
Q4 | $2.14M | Buy |
|